
Health
The FDA now says Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss
By Katherine Langford
Advertisement · Why this ad?

Weizmann Institute of Science and University of Minnesota researchers say programming synthetic matter with DNA could advance targeted medical therapies and flexible soft robotics